| Literature DB >> 23047663 |
Hidenobu Takami1, Mariko Nakamoto, Hirokazu Uemura, Sakurako Katsuura, Miwa Yamaguchi, Mineyoshi Hiyoshi, Fusakazu Sawachika, Tomoya Juta, Kokichi Arisawa.
Abstract
BACKGROUND: It is unclear whether consumption of coffee and green tea is associated with metabolic syndrome.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23047663 PMCID: PMC3700235 DOI: 10.2188/jea.je20120053
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Characteristics of the study participants
| Men (No. = 409) | Women (No. = 145) | |
| Age (years)a | 52.2 (9.4) | 52.4 (9.1) |
| Height (cm)a | 169.3 (5.9) | 156.6 (6.1) |
| Weight (kg)a | 69.5 (11.1) | 55.5 (7.4) |
| Body mass index (kg/m2)a | 24.2 (3.3) | 22.7 (3.2) |
| Waist circumference (cm)a | 86.0 (9.0) | 80.3 (9.3) |
| Systolic blood pressure (mm Hg)a | 120.1 (14.6) | 115.3 (15.2) |
| Diastolic blood pressure (mm Hg)a | 73.7 (10.6) | 68.5 (10.5) |
| Triglycerides (mg/dl)b | 103 (73, 149) | 79 (59, 109) |
| High-density lipoprotein cholesterol (mg/dl)a | 55.5 (16.6) | 65.9 (14.4) |
| Fasting plasma glucose (mg/dl)a | 102.7 (23.2) | 97.9 (24.6) |
| Total energy intake (kcal/day)a | 1902 (332) | 1539 (220) |
| Physical activity (MET-hours/week)b | 7.7 (1.3, 21.9) | 5.1 (0.4, 15.3) |
| Coffee consumption (cups/week)b | 11.5 (5.6, 24.6) | 10.6 (3.6, 11.5) |
| Green tea consumption (cups/day)b | 2 (2, 2) | 2 (2, 5) |
| Smoking habit (No., %) | ||
| Current | 109 (26.7) | 12 (8.3) |
| Past | 169 (41.3) | 15 (10.3) |
| No | 131 (32.0) | 118 (81.4) |
| Drinking habit (No., %) | ||
| Current | 306 (74.8) | 59 (40.7) |
| Past | 7 (1.7) | 2 (1.4) |
| No | 96 (23.5) | 84 (57.9) |
aMean (SD).
bMedian (25%, 75%).
Associations of coffee consumption with the prevalence of metabolic syndrome and its components according to NCEP ATP III criteria (No. = 554)
| Coffee consumption (cups/day) | ||||
| <1.5 | ≥1.5 and <3 | ≥3 | ||
| Metabolic syndrome | ||||
| No. of cases/subjects | 47/168 | 34/193 | 33/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.60 (0.36–0.99) | 0.61 (0.36–1.03) | 0.06 |
| Adjustedb OR (95% CI) | 1.00 | 0.56 (0.33–0.95) | 0.55 (0.31–0.94) | 0.03 |
| Waist circumference ≥90 cm in men and ≥80 cm in women | ||||
| No. of cases/subjects | 62/168 | 73/193 | 72/193 | |
| Adjusteda OR (95% CI) | 1.00 | 1.02 (0.66–1.60) | 1.28 (0.82–2.03) | 0.27 |
| Adjustedb OR (95% CI) | 1.00 | 1.06 (0.67–1.67) | 1.31 (0.82–2.10) | 0.25 |
| Triglycerides ≥150 mg/dl | ||||
| No. of cases/subjects | 45/168 | 36/193 | 40/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.64 (0.38–1.05) | 0.61 (0.37–1.02) | 0.06 |
| Adjustedb OR (95% CI) | 1.00 | 0.60 (0.35–1.02) | 0.53 (0.31–0.90) | 0.02 |
| High-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women | ||||
| No. of cases/subjects | 27/168 | 20/193 | 27/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.62 (0.33–1.16) | 0.92 (0.50–1.68) | 0.77 |
| Adjustedb OR (95% CI) | 1.00 | 0.56 (0.29–1.07) | 0.69 (0.37–1.31) | 0.27 |
| Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment | ||||
| No. of cases/subjects | 62/168 | 61/193 | 49/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.97 (0.61–1.55) | 0.79 (0.48–1.28) | 0.34 |
| Adjustedb OR (95% CI) | 1.00 | 0.89 (0.55–1.45) | 0.82 (0.49–1.36) | 0.44 |
| Fasting plasma glucose ≥100 mg/dl or diabetes treatment | ||||
| No. of cases/subjects | 77/168 | 68/193 | 79/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.74 (0.48–1.16) | 0.86 (0.55–1.35) | 0.53 |
| Adjustedb OR (95% CI) | 1.00 | 0.74 (0.47–1.18) | 0.81 (0.51–1.30) | 0.40 |
aAdjusted for age and sex.
bAdjusted for age, sex, total energy intake, physical activity, and smoking and drinking habits.
Associations of coffee consumption with the prevalence of metabolic syndrome and its components according to JASSO criteria (No. = 554)
| Coffee consumption (cups/day) | ||||
| <1.5 | ≥1.5 and <3 | ≥3 | ||
| Metabolic syndrome | ||||
| No. of cases/subjects | 32/168 | 21/193 | 24/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.58 (0.31–1.05) | 0.62 (0.34–1.12) | 0.10 |
| Adjustedb OR (95% CI) | 1.00 | 0.52 (0.27–0.97) | 0.59 (0.32–1.10) | 0.09 |
| Waist circumference ≥85 cm in men and ≥90 cm in women | ||||
| No. of cases/subjects | 76/168 | 72/193 | 91/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.81 (0.52–1.29) | 0.94 (0.60–1.48) | 0.83 |
| Adjustedb OR (95% CI) | 1.00 | 0.77 (0.48–1.23) | 0.93 (0.58–1.49) | 0.81 |
| Triglycerides ≥150 mg/dl or high-density lipoprotein cholesterol <40 mg/dl | ||||
| No. of cases/subjects | 54/168 | 44/193 | 49/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.65 (0.40–1.04) | 0.63 (0.39–1.01) | 0.05 |
| Adjustedb OR (95% CI) | 1.00 | 0.61 (0.37–1.00) | 0.54 (0.33–0.89) | 0.02 |
| High-density lipoprotein cholesterol <40 mg/dl | ||||
| No. of cases/subjects | 18/168 | 18/193 | 24/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.93 (0.46–1.88) | 1.09 (0.56–2.15) | 0.79 |
| Adjustedb OR (95% CI) | 1.00 | 0.83 (0.40–1.74) | 0.84 (0.41–1.72) | 0.65 |
| Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment | ||||
| No. of cases/subjects | 62/168 | 61/193 | 49/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.97 (0.61–1.55) | 0.79 (0.48–1.28) | 0.34 |
| Adjustedb OR (95% CI) | 1.00 | 0.89 (0.55–1.45) | 0.82 (0.49–1.36) | 0.44 |
| Fasting plasma glucose ≥110 mg/dl or diabetes treatment | ||||
| No. of cases/subjects | 40/168 | 22/193 | 27/193 | |
| Adjusteda OR (95% CI) | 1.00 | 0.49 (0.27–0.87) | 0.64 (0.36–1.13) | 0.10 |
| Adjustedb OR (95% CI) | 1.00 | 0.51 (0.28–0.93) | 0.65 (0.36–1.17) | 0.13 |
aAdjusted for age and sex.
bAdjusted for age, sex, total energy intake, physical activity, and smoking and drinking habits.
Associations of green tea consumption with the prevalence of metabolic syndrome and its components according NCEP ATP III criteria (No. = 554)
| Green tea consumption (cups/day) | ||||
| <1 | ≥1 and ≤3 | ≥4 | ||
| Metabolic syndrome | ||||
| No. of cases/subjects | 16/89 | 60/310 | 38/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.00 (0.55–1.90) | 1.25 (0.64–2.50) | 0.43 |
| Adjustedb OR (95% CI) | 1.00 | 1.01 (0.54–1.95) | 1.14 (0.57–2.34) | 0.66 |
| Waist circumference ≥90 cm in men and ≥80 cm in women | ||||
| No. of cases/subjects | 30/89 | 115/310 | 62/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.15 (0.70–1.93) | 0.99 (0.56–1.77) | 0.85 |
| Adjustedb OR (95% CI) | 1.00 | 1.21 (0.72–2.07) | 1.01 (0.56–1.83) | 0.88 |
| Triglycerides ≥150 mg/dl | ||||
| No. of cases/subjects | 17/89 | 73/310 | 31/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.31 (0.74–2.44) | 1.28 (0.65–2.56) | 0.55 |
| Adjustedb OR (95% CI) | 1.00 | 1.38 (0.76–2.63) | 1.18 (0.59–2.44) | 0.76 |
| High-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women | ||||
| No. of cases/subjects | 9/89 | 40/310 | 25/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.28 (0.62–2.92) | 1.61 (0.72–3.89) | 0.24 |
| Adjustedb OR (95% CI) | 1.00 | 1.23 (0.58–2.88) | 1.49 (0.64–3.69) | 0.35 |
| Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment | ||||
| No. of cases/subjects | 23/89 | 90/310 | 59/155 | |
| Adjusteda OR (95% CI) | 1.00 | 0.97 (0.55–1.72) | 1.28 (0.69–2.40) | 0.33 |
| Adjustedb OR (95% CI) | 1.00 | 1.01 (0.57–1.82) | 1.21 (0.64–2.32) | 0.49 |
| Fasting plasma glucose ≥100 mg/dl or diabetes treatment | ||||
| No. of cases/subjects | 41/89 | 123/310 | 60/155 | |
| Adjusteda OR (95% CI) | 1.00 | 0.64 (0.39–1.05) | 0.68 (0.38–1.20) | 0.26 |
| Adjustedb OR (95% CI) | 1.00 | 0.63 (0.38–1.07) | 0.73 (0.40–1.32) | 0.40 |
aAdjusted for age and sex.
bAdjusted for age, sex, total energy intake, physical activity, smoking and drinking habits, and coffee consumption.
Associations of green tea consumption with the prevalence of metabolic syndrome and its components according to JASSO criteria (No. = 554)
| Green tea consumption (cups/day) | ||||
| <1 | ≥1 and ≤3 | ≥4 | ||
| Metabolic syndrome | ||||
| No. of cases/subjects | 11/89 | 41/310 | 25/155 | |
| Adjusteda OR (95% CI) | 1.00 | 0.98 (0.49–2.09) | 1.38 (0.64–3.14) | 0.33 |
| Adjustedb OR (95% CI) | 1.00 | 0.99 (0.49–2.17) | 1.18 (0.53–2.75) | 0.63 |
| Waist circumference ≥85 cm in men and ≥90 cm in women | ||||
| No. of cases/subjects | 37/89 | 145/310 | 57/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.13 (0.68–1.88) | 1.00 (0.56–1.81) | 0.93 |
| Adjustedb OR (95% CI) | 1.00 | 1.13 (0.67–1.90) | 0.87 (0.48–1.60) | 0.57 |
| Triglycerides ≥150 mg/dl or high-density lipoprotein cholesterol <40 mg/dl | ||||
| No. of cases/subjects | 20/89 | 90/310 | 37/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.39 (0.80–2.48) | 1.29 (0.68–2.48) | 0.54 |
| Adjustedb OR (95% CI) | 1.00 | 1.43 (0.81–2.61) | 1.18 (0.61–2.33) | 0.77 |
| High-density lipoprotein cholesterol <40 mg/dl | ||||
| No. of cases/subjects | 7/89 | 36/310 | 17/155 | |
| Adjusteda OR (95% CI) | 1.00 | 1.49 (0.67–3.78) | 1.74 (0.70–4.76) | 0.27 |
| Adjustedb OR (95% CI) | 1.00 | 1.44 (0.63–3.75) | 1.64 (0.63–4.65) | 0.34 |
| Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment | ||||
| No. of cases/subjects | 23/89 | 90/310 | 59/155 | |
| Adjusteda OR (95% CI) | 1.00 | 0.97 (0.55–1.72) | 1.28 (0.69–2.40) | 0.33 |
| Adjustedb OR (95% CI) | 1.00 | 1.01 (0.57–1.82) | 1.21 (0.64–2.32) | 0.49 |
| Fasting plasma glucose ≥110 mg/dl or diabetes treatment | ||||
| No. of cases/subjects | 14/89 | 49/310 | 26/155 | |
| Adjusteda OR (95% CI) | 1.00 | 0.83 (0.43–1.68) | 0.84 (0.40–1.81) | 0.70 |
| Adjustedb OR (95% CI) | 1.00 | 0.84 (0.43–1.71) | 0.84 (0.39–1.86) | 0.70 |
aAdjusted for age and sex.
bAdjusted for age, sex, total energy intake, physical activity, smoking and drinking habits, and coffee consumption.